Mostrar el registro sencillo del ítem

dc.contributor.authorVilas, Jéssica M
dc.contributor.authorFerreirós, Alba
dc.contributor.authorCarneiro, Carmen
dc.contributor.authorMorey, Lluis
dc.contributor.authorDa Silva-Álvarez, Sabela
dc.contributor.authorFernandes, Tânia
dc.contributor.authorDi Croce, Luciano
dc.contributor.authorGarcía-Caballero, Tomás
dc.contributor.authorRivas, Carmen
dc.contributor.authorVidal, Anxo
dc.contributor.authorSerrano Marugan, Manuel 
dc.date.accessioned2020-06-11T16:23:01Z
dc.date.available2020-06-11T16:23:01Z
dc.date.issued2015-02-20
dc.identifier.citationOncotarget .2015;6(5):2992-3002.es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/10360
dc.description.abstractCellular reprogramming to iPSCs has uncovered unsuspected links between tumor suppressors and pluripotency factors. Using this system, it was possible to identify tumor suppressor p27 as a repressor of Sox2 during differentiation. This led to the demonstration that defects in the repression of Sox2 can contribute to tumor development. The members of the retinoblastoma family of pocket proteins, pRb, p107 and p130, are negative regulators of the cell cycle with tumor suppressor activity and with roles in differentiation. In this work we studied the relative contribution of the retinoblastoma family members to the regulation of Sox2 expression. We found that deletion of Rb or p130 leads to impaired repression of Sox2, a deffect amplified by inactivation of p53. We also identified binding of pRb and p130 to an enhancer with crucial regulatory activity on Sox2 expression. Using cellular reprogramming we tested the impact of the defective repression of Sox2 and confirmed that Rb deficiency allows the generation of iPSCs in the absence of exogenous Sox2. Finally, partial depletion of Sox2 positive cells reduced the pituitary tumor development initiated by Rb loss in vivo. In summary, our results show that Sox2 repression by pRb is a relevant mechanism of tumor suppression.es_ES
dc.description.sponsorshipWe acknowledge the technical assistance of Pilar Alvarino. We are indebted to Patricia Viano for expert assistance with histological analysis. We thank Patricia Gonzalez, Maria Gomez and Virginia Alvarez for expert technical help with immunohistochemistry, and Han Li for critical reading of the manuscript. We are indebted to Konrad Hochedlinger for Sox2-TK ES cells. J.M.V. is a Xunta de Galicia predoctoral fellow. A.F. is an FPU predoctoral fellow from MECD. M.C. is a "Miguel Servet" investigator (ISCIII). Work in the laboratory of M.C. is funded by ISCIII (CP/11/00273). Work at the laboratory of A.V. is supported by grants from Xunta de Galicia (EM 2012/061) and MICINN (SAF2009-07389).es_ES
dc.language.isoenges_ES
dc.publisherImpact Journals es_ES
dc.type.hasVersionVoRes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subjectIPS CELLSes_ES
dc.subjectRB FAMILYes_ES
dc.subjectSTEMes_ES
dc.subjectSUPPRESSIONes_ES
dc.subjectPATHWAYes_ES
dc.subjectMOUSEes_ES
dc.subjectGENEes_ES
dc.subjectMECHANISMSes_ES
dc.subjectMICEes_ES
dc.subject.meshTranscription, Genetic es_ES
dc.subject.meshAnimals es_ES
dc.subject.meshCellular Reprogramming es_ES
dc.subject.meshEpigenesis, Genetic es_ES
dc.subject.meshGene Expression Regulation, Developmental es_ES
dc.subject.meshGene Expression Regulation, Neoplastic es_ES
dc.subject.meshGenotype es_ES
dc.subject.meshHEK293 Cells es_ES
dc.subject.meshHumans es_ES
dc.subject.meshInduced Pluripotent Stem Cells es_ES
dc.subject.meshMice, 129 Strain es_ES
dc.subject.meshMice, Inbred C57BL es_ES
dc.subject.meshMice, Knockout es_ES
dc.subject.meshNeoplastic Stem Cells es_ES
dc.subject.meshPhenotype es_ES
dc.subject.meshPituitary Neoplasms es_ES
dc.subject.meshRNA Interference es_ES
dc.subject.meshRetinoblastoma Protein es_ES
dc.subject.meshRetinoblastoma-Like Protein p107 es_ES
dc.subject.meshRetinoblastoma-Like Protein p130 es_ES
dc.subject.meshSOXB1 Transcription Factors es_ES
dc.subject.meshTransfection es_ES
dc.subject.meshTumor Suppressor Protein p53 es_ES
dc.titleTranscriptional regulation of Sox2 by the retinoblastoma family of pocket proteins.es_ES
dc.typejournal articlees_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.identifier.pubmedID25576924es_ES
dc.format.volume6es_ES
dc.format.number5es_ES
dc.format.page2992-3002es_ES
dc.identifier.doi10.18632/oncotarget.2996es_ES
dc.contributor.funderInstituto de Salud Carlos III 
dc.contributor.funderXunta de Galicia (España) 
dc.contributor.funderMinisterio de Economía y Competitividad (España) 
dc.description.peerreviewedes_ES
dc.identifier.e-issn1949-2553es_ES
dc.relation.publisherversionhttps://doi.org/10.18632/oncotarget.2996es_ES
dc.identifier.journalOncotargetes_ES
dc.repisalud.institucionCNIOes_ES
dc.repisalud.orgCNIOCNIO::Grupos de investigación::Antiguos CNIOes_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/SAF2009-07389es_ES
dc.relation.projectIDinfo:eu_repo/grantAgreement/ES/CP/11/00273es_ES
dc.rights.accessRightsopen accesses_ES


Ficheros en el ítem

Acceso Abierto
Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución-NoComercial-CompartirIgual 4.0 Internacional
Este Item está sujeto a una licencia Creative Commons: Atribución-NoComercial-CompartirIgual 4.0 Internacional